Your browser doesn't support javascript.
loading
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
Bär, Sofia Isolde; Dittmer, Alexandra; Nitzsche, Bianca; Ter-Avetisyan, Gohar; Fähling, Michael; Klefenz, Adrian; Kaps, Leonard; Biersack, Bernhard; Schobert, Rainer; Höpfner, Michael.
Afiliación
  • Bär SI; Organic Chemistry Laboratory, University of Bayreuth, D-95447 Bayreuth, Germany.
  • Dittmer A; Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, D-10117 Berlin, Germany.
  • Nitzsche B; Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, D-10117 Berlin, Germany.
  • Ter-Avetisyan G; Institute of Vegetative Physiology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, D-10117 Berlin, Germany.
  • Fähling M; Institute of Vegetative Physiology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, D-10117 Berlin, Germany.
  • Klefenz A; Institute of Translational Immunology, University Medical Center of the Johannes Gutenberg University, D-55131 Mainz, Germany.
  • Kaps L; Institute of Translational Immunology, University Medical Center of the Johannes Gutenberg University, D-55131 Mainz, Germany.
  • Biersack B; Organic Chemistry Laboratory, University of Bayreuth, D-95447 Bayreuth, Germany.
  • Schobert R; Organic Chemistry Laboratory, University of Bayreuth, D-95447 Bayreuth, Germany.
  • Höpfner M; Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, D-10117 Berlin, Germany.
Int J Oncol ; 60(6)2022 Jun.
Article en En | MEDLINE | ID: mdl-35485292
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Int J Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Int J Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Grecia